abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

이 페이지는 한국어로 제공되지 않으며 English로 표시됩니다.

기사

2021년 7월 1일

저자:
Sarah Maslin Nir, New York Times (France)

USA: Pharmaceutical companies & pharmacy chains to face trial by jury over role in opioid crisis

"An Opioid Case Like No Other: N.Y. vs. the Entire Supply Chain", 29 Jun 2021

When New York’s sprawling opioid trial — the first in the country that targets the entire opioid supply chain — begins with opening arguments in Central Islip on Long Island on Tuesday, it will not be held in a courthouse.

There was not a courtroom large enough to fit the eight defendants, including drugmakers who manufacture opioids, distributors that supply the pills, their subsidiaries and their armies of lawyers. The judge will hear the case in an auditorium at a local college.

The trial, in which Nassau and Suffolk Counties have joined the New York State attorney general, marks the first opioid case where a jury rather than a judge will decide the outcome. Initially, the sweeping case also targeted several pharmacy chains that dispensed opioids, but in the days leading up to the trial, all were excised from the case following a flurry of settlements with New York, the details of which have not yet been finalized.

Still, the proceedings will offer rare illumination of the machinery that helped power a drug scourge that over the past two decades has killed more than 800,000 people nationwide via overdoses of prescription and street opioids, according to federal data...

Conspicuously absent from the makeshift courtroom will be the defendant most associated by the public as culpable for the two-decade-long opioid epidemic — Purdue Pharma, the maker of OxyContin, which is owned by members of the billionaire Sackler family.

Purdue was initially named in the case, as were some individual Sacklers. But nearly two years ago, as Purdue faced thousands of opioid-related lawsuits, it filed for bankruptcy, a process that has paused cases against it and the Sacklers...

The New York complaint also had named as defendants four major pharmacy chains: Walmart, CVS, Rite Aid and Walgreens. But in the weeks leading up to the trial, all but Walgreens were severed from the case.

A spokesman for CVS confirmed that the pharmacy had reached a settlement agreement with Nassau and Suffolk Counties, the terms of which must be approved by the county legislatures before any financial payout is determined.

Rite Aid, Walmart and Walgreens did not respond to emails requesting comment. Lawyers for the counties declined to comment on the details of the pharmacies’ severance.

Even without the companies that have settled, a broad swath of the opioid industry is still set to take the stand, including manufacturers of generic versions of drugs, like Teva Pharmaceutical Industries Ltd. and Allergan Inc., as well as massive suppliers of the pills such as Cardinal Health and McKesson Corp...

Any money recovered will not go to people harmed by the opioid crisis, but rather toward abatement — mitigating harm and preventing future crises with things like education and addiction treatment programs...

개인정보

이 웹사이트는 쿠키 및 기타 웹 저장 기술을 사용합니다. 아래에서 개인정보보호 옵션을 설정할 수 있습니다. 변경 사항은 즉시 적용됩니다.

웹 저장소 사용에 대한 자세한 내용은 다음을 참조하세요 데이터 사용 및 쿠키 정책

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

분석 쿠키

ON
OFF

귀하가 우리 웹사이트를 방문하면 Google Analytics를 사용하여 귀하의 방문 정보를 수집합니다. 이 쿠키를 수락하면 저희가 귀하의 방문에 대한 자세한 내용을 이해하고, 정보 표시 방법을 개선할 수 있습니다. 모든 분석 정보는 익명이 보장되며 귀하를 식별하는데 사용하지 않습니다. Google은 모든 브라우저에 대해 Google Analytics 선택 해제 추가 기능을 제공합니다.

프로모션 쿠키

ON
OFF

우리는 소셜미디어와 검색 엔진을 포함한 제3자 플랫폼을 통해 기업과 인권에 대한 뉴스와 업데이트를 제공합니다. 이 쿠키는 이러한 프로모션의 성과를 이해하는데 도움이 됩니다.

이 사이트에 대한 개인정보 공개 범위 선택

이 사이트는 필요한 핵심 기능 이상으로 귀하의 경험을 향상시키기 위해 쿠키 및 기타 웹 저장 기술을 사용합니다.